ERBB2 and breast cancer: We analysed a large and well-characterized cohort of breast cancer cases with complete data on classical prognostic factors and relevant molecular markers, such as oestrogen receptor (ER), progesterone receptor (PgR) and HER2 as well as Cathepsin D’s role in response to tamoxifen therapy.